Amorfix Life Sciences Ltd. Announces Third Quarter Fiscal 2008 Results
TORONTO, Feb. 8 /CNW/ - Amorfix Life Sciences (TSX: AMF), a company
focused on treatments and diagnostics for brain-wasting diseases, today
reported its third quarter operating results and provided an update on the
Company's diagnostic and therapeutic programs.